Jennifer B. Green
0000-0002-9967-5352
Publication & Citation Trends
Publications
0 total
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial
Cited by 0
Semantic Scholar
Sequence-Dependent Amplification of Gabapentinoid-Associated Dementia Risk by Dihydropyridine Calcium Channel Blockers: Asymmetric Pharmacodynamic Vulnerability Consistent with Homeostatic Synaptic Plasticity
Cited by 0
Semantic Scholar
Reversibility of Cognitive Effects Associated with Concomitant Gabapentin and Dihydropyridine Calcium Channel Blocker Use
Cited by 0
Semantic Scholar
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone
Cited by 0
Semantic Scholar
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.
Cited by 4
Semantic Scholar
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.
Cited by 1
Semantic Scholar
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.
Cited by 1
Semantic Scholar
Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review OA
Cited by 1
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(105)
Diabetes Management and Research
(50)
Cardiovascular Function and Risk Factors
(30)
Metabolism, Diabetes, and Cancer
(27)
Diabetes, Cardiovascular Risks, and Lipoproteins
(17)
Affiliations
University of North Carolina at Chapel Hill
Texas Tech University
University of Iowa
Oslo University Hospital
Merck & Co., Inc., Rahway, NJ, USA (United States)